Director sell down - 23 million ?, page-10

Hi V,

I've only been watching the market for a bit over 5 years but this is the most volatile stock I've ever seen. Personally I invested on the basis of Nunyara but I do like the promise of the industry generally. The plummet seen since the CR at $3.90 is remarkable. The lawsuits and FDA regulatory action has seen a general pull back in the sector. However the exit from Japan and the financial process of transitioning the business has made it easy to talk and sell EXL down. The plummet may have something to do with the type of investor that held the stock. There was a comprehensive media campaign alerting potential investors to the stock . I see a lot of jibes on Motley Fool FB posts now about their promotion of EXL and the losses taken. The price of being one of the herd I guess. Anyway, for me the Japan exit at a cost of $3M is chicken feed really and there's is nothing in the financials that scare me. In fact, the Board advised that the expected increase in revenue would only start to be seen in this last quarter and the spending had to be expected given their strategy. I like how the Board has been so proactive in it's support of regulation and how they handled the Japan exit. I did have it has a buy from .70c and just changed to hold again, Topped up at 57.5c which is something I never do as I usually just buy to hold but couldn't understand the falls given the information available through announcements. I remain confident that this company is a good long term hold.